Trial Profile
Comparative Therapeutic Efficacy and Safety of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Mar 2023
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Remdesivir (Primary)
- Indications SARS-CoV-2 acute respiratory disease
- Focus Therapeutic Use
- 24 Mar 2021 New trial record